Published in Blood Weekly, June 12th, 2003
"Previous data indicate that a transfer of specific humoral and cellular immunity by way of allogeneic hematopoietic cell transplantation (HCT) should, in principle, be possible," explained Monika Lindemann and colleagues at the University of Essen and Georg-August University in Goettingen.
Recipients of stem cell grafts from vaccinated donors demonstrated HBV-specific immune responses after transplantation, Lindemann and coauthors confirmed.
The researchers examined cellular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-06-12)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.